FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016046870> ?p ?o ?g. }

• W2016046870 endingPage "1524" @default.
• W2016046870 startingPage "1520" @default.
• W2016046870 abstract "Article AbstractBackground: Among antidepressant augmentation strategies, the addition of a stimulant to a monoamine oxidase inhibitor (MAOI) has received little attention in the literature in recent years because of the diminished clinical use of the latter and concerns of precipitating a hypertensive crisis or other serious complication. Despite that fact, experienced clinicians continue to use this combination for a variety of indications after other options have failed. This article reviews these reported uses and presents a case suggesting another possible indication. Method: A MEDLINE search was conducted for articles published from 1962 to December 2003 using relevant search terms (psychostimulant, stimulant, amphetamine, dextroamphetamine, pemoline or methylphenidate, atomoxetine, bupropion, monoamine oxidase inhibitor, and selegiline). A manual search was conducted of cross-references and other relevant recent psychiatric sources (2000-2003). Results: The described uses of the MAOI-stimulant combination have included treatment of refractory depression and the MAOI-related side effects of orthostatic hypotension and daytime sedation. No documented reports were found in the recent literature of hypertensive crises or fatalities occurring when the stimulant was cautiously added to the MAOI. Also presented here is another possible indication for this therapeutic regimen: treatment of attention-deficit/hyperactivity disorder in an adult patient whose major depression had uniquely responded to the MAOI tranylcypromine. Conclusion: As in other fields of medicine, potentially hazardous medication combinations are utilized in psychiatry after cautiously weighing the danger of the treatment against the morbidity and risk of not adequately addressing the illness. Particularly, as the potential arrival of the apparently safer transdermal selegiline may increase the use of MAOIs, we feel this combination deserves additional controlled study." @default.
• W2016046870 created "2016-06-24" @default.
• W2016046870 creator A5030486812 @default.
• W2016046870 date "2004-11-15" @default.
• W2016046870 modified "2023-10-18" @default.
• W2016046870 title "Combining Stimulants With Monoamine Oxidase Inhibitors" @default.
• W2016046870 doi "https://doi.org/10.4088/jcp.v65n1113" @default.
• W2016046870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15554766" @default.
• W2016046870 hasPublicationYear "2004" @default.
• W2016046870 type Work @default.
• W2016046870 sameAs 2016046870 @default.
• W2016046870 citedByCount "48" @default.
• W2016046870 countsByYear W20160468702012 @default.
• W2016046870 countsByYear W20160468702014 @default.
• W2016046870 countsByYear W20160468702015 @default.
• W2016046870 countsByYear W20160468702016 @default.
• W2016046870 countsByYear W20160468702017 @default.
• W2016046870 countsByYear W20160468702018 @default.
• W2016046870 countsByYear W20160468702019 @default.
• W2016046870 countsByYear W20160468702021 @default.
• W2016046870 countsByYear W20160468702022 @default.
• W2016046870 countsByYear W20160468702023 @default.
• W2016046870 crossrefType "journal-article" @default.
• W2016046870 hasAuthorship W2016046870A5030486812 @default.
• W2016046870 hasConcept C118552586 @default.
• W2016046870 hasConcept C126322002 @default.
• W2016046870 hasConcept C139719470 @default.
• W2016046870 hasConcept C142724271 @default.
• W2016046870 hasConcept C15744967 @default.
• W2016046870 hasConcept C162324750 @default.
• W2016046870 hasConcept C170493617 @default.
• W2016046870 hasConcept C181199279 @default.
• W2016046870 hasConcept C185592680 @default.
• W2016046870 hasConcept C2775864247 @default.
• W2016046870 hasConcept C2776024655 @default.
• W2016046870 hasConcept C2776134090 @default.
• W2016046870 hasConcept C2776867660 @default.
• W2016046870 hasConcept C2777112843 @default.
• W2016046870 hasConcept C2777118369 @default.
• W2016046870 hasConcept C2777193897 @default.
• W2016046870 hasConcept C2777843972 @default.
• W2016046870 hasConcept C2778630814 @default.
• W2016046870 hasConcept C2778781522 @default.
• W2016046870 hasConcept C2779134260 @default.
• W2016046870 hasConcept C2779177272 @default.
• W2016046870 hasConcept C2779734285 @default.
• W2016046870 hasConcept C2779908668 @default.
• W2016046870 hasConcept C2780179036 @default.
• W2016046870 hasConcept C2780557958 @default.
• W2016046870 hasConcept C2780783007 @default.
• W2016046870 hasConcept C37000724 @default.
• W2016046870 hasConcept C513476851 @default.
• W2016046870 hasConcept C55493867 @default.
• W2016046870 hasConcept C558461103 @default.
• W2016046870 hasConcept C71924100 @default.
• W2016046870 hasConceptScore W2016046870C118552586 @default.
• W2016046870 hasConceptScore W2016046870C126322002 @default.
• W2016046870 hasConceptScore W2016046870C139719470 @default.
• W2016046870 hasConceptScore W2016046870C142724271 @default.
• W2016046870 hasConceptScore W2016046870C15744967 @default.
• W2016046870 hasConceptScore W2016046870C162324750 @default.
• W2016046870 hasConceptScore W2016046870C170493617 @default.
• W2016046870 hasConceptScore W2016046870C181199279 @default.
• W2016046870 hasConceptScore W2016046870C185592680 @default.
• W2016046870 hasConceptScore W2016046870C2775864247 @default.
• W2016046870 hasConceptScore W2016046870C2776024655 @default.
• W2016046870 hasConceptScore W2016046870C2776134090 @default.
• W2016046870 hasConceptScore W2016046870C2776867660 @default.
• W2016046870 hasConceptScore W2016046870C2777112843 @default.
• W2016046870 hasConceptScore W2016046870C2777118369 @default.
• W2016046870 hasConceptScore W2016046870C2777193897 @default.
• W2016046870 hasConceptScore W2016046870C2777843972 @default.
• W2016046870 hasConceptScore W2016046870C2778630814 @default.
• W2016046870 hasConceptScore W2016046870C2778781522 @default.
• W2016046870 hasConceptScore W2016046870C2779134260 @default.
• W2016046870 hasConceptScore W2016046870C2779177272 @default.
• W2016046870 hasConceptScore W2016046870C2779734285 @default.
• W2016046870 hasConceptScore W2016046870C2779908668 @default.
• W2016046870 hasConceptScore W2016046870C2780179036 @default.
• W2016046870 hasConceptScore W2016046870C2780557958 @default.
• W2016046870 hasConceptScore W2016046870C2780783007 @default.
• W2016046870 hasConceptScore W2016046870C37000724 @default.
• W2016046870 hasConceptScore W2016046870C513476851 @default.
• W2016046870 hasConceptScore W2016046870C55493867 @default.
• W2016046870 hasConceptScore W2016046870C558461103 @default.
• W2016046870 hasConceptScore W2016046870C71924100 @default.
• W2016046870 hasIssue "11" @default.
• W2016046870 hasLocation W20160468701 @default.
• W2016046870 hasLocation W20160468702 @default.
• W2016046870 hasOpenAccess W2016046870 @default.
• W2016046870 hasPrimaryLocation W20160468701 @default.
• W2016046870 hasRelatedWork W1596856744 @default.
• W2016046870 hasRelatedWork W1813726663 @default.
• W2016046870 hasRelatedWork W191066137 @default.
• W2016046870 hasRelatedWork W2016046870 @default.
• W2016046870 hasRelatedWork W2084578728 @default.
• W2016046870 hasRelatedWork W2085830927 @default.
• W2016046870 hasRelatedWork W2413440761 @default.

• next